Siddharth S. Kesharwani

Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer

Rakesh Dachineni, Dileep Kumar, Eduardo Callegari et al. · International Journal of Oncology · 2017 · 90 citations · Full text

Medicine, Oncology, Pharmacology +16

The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention

Ranjini Sankaranarayanan, Chaitanya K. Valiveti, Dinesh Kumar et al. · Cancers · 2019 · 77 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +7

Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): Formulation development, characterization and pharmacological evaluation

Siddharth S. Kesharwani, Rizwan Ahmad, Mohammed Ali Bakkari et al. · Journal of Controlled Release · 2018 · 74 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin

Sunny Kumar, Siddharth S. Kesharwani, Himanshi Mathur et al. · European Journal of Pharmaceutical Sciences · 2015 · 70 citations

Pharmacy, Chemistry, Materials Science +15

Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route

Pratik Muley, Sunny Kumar, Fadoua El Kourati et al. · International Journal of Pharmaceutics · 2016 · 67 citations

Pharmacy, Pharmaceutics, Pharmacology +16